Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Drug-eluting fibers for HIV-1 inhibition and contraception.

Ball C, Krogstad E, Chaowanachan T, Woodrow KA.

PLoS One. 2012;7(11):e49792. doi: 10.1371/journal.pone.0049792. Epub 2012 Nov 28.

2.

Combining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies: Development of dual-protection technologies.

Friend DR, Doncel GF.

Antiviral Res. 2010 Dec;88 Suppl 1:S47-54. doi: 10.1016/j.antiviral.2010.09.005. Review.

PMID:
21109068
3.

Multipurpose prevention technologies: products in development.

Friend DR, Clark JT, Kiser PF, Clark MR.

Antiviral Res. 2013 Dec;100 Suppl:S39-47. doi: 10.1016/j.antiviral.2013.09.030. Epub 2013 Nov 1. Review.

PMID:
24188708
4.

Delivery of multipurpose prevention drug combinations from electrospun nanofibers using composite microarchitectures.

Blakney AK, Krogstad EA, Jiang YH, Woodrow KA.

Int J Nanomedicine. 2014 Jun 17;9:2967-78. doi: 10.2147/IJN.S61664. eCollection 2014.

5.

Beyond HIV microbicides: multipurpose prevention technology products.

Malcolm RK, Boyd P, McCoy CF, Murphy DJ.

BJOG. 2014 Oct;121 Suppl 5:62-9. doi: 10.1111/1471-0528.12852.

6.

Electrospun fibers for vaginal anti-HIV drug delivery.

Blakney AK, Ball C, Krogstad EA, Woodrow KA.

Antiviral Res. 2013 Dec;100 Suppl:S9-16. doi: 10.1016/j.antiviral.2013.09.022. Epub 2013 Nov 1. Review.

PMID:
24188701
7.

Research. Spun cloth may provide another option for HIV protection.

[No authors listed]

AIDS Policy Law. 2013 Jan;28(3):3. No abstract available.

PMID:
23476951
8.

The dual goals of reproductive health.

Cates W Jr.

Netw Res Triangle Park N C. 1996 Spring;16(3):3 p.

PMID:
12293921
9.

Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission.

Friend DR.

Expert Opin Drug Deliv. 2012 Apr;9(4):417-27. doi: 10.1517/17425247.2012.668183. Epub 2012 Mar 2. Review.

PMID:
22385316
10.

Multipurpose prevention technologies: biomedical tools to prevent HIV-1, HSV-2, and unintended pregnancies.

Thurman AR, Clark MR, Doncel GF.

Infect Dis Obstet Gynecol. 2011;2011:1-10. doi: 10.1155/2011/429403. Epub 2011 Aug 9. Review.

11.

Prioritizing multipurpose prevention technology development and investments using a target product profile.

Romano J, Manning J, Hemmerling A, McGrory E, Holt BY.

Antiviral Res. 2013 Dec;100 Suppl:S32-8. doi: 10.1016/j.antiviral.2013.09.016. Epub 2013 Nov 1.

PMID:
24188707
12.

Multipurpose prevention technologies for reproductive and sexual health.

Stone A.

Reprod Health Matters. 2014 Nov;22(44):213-7. doi: 10.1016/S0968-8080(14)44801-8.

PMID:
25555778
13.

Lessons from reproductive health to inform multipurpose prevention technologies: don't reinvent the wheel.

Brady M, Manning J.

Antiviral Res. 2013 Dec;100 Suppl:S25-31. doi: 10.1016/j.antiviral.2013.09.019. Epub 2013 Nov 1. Review.

PMID:
24188700
14.

Exploiting common targets in human fertilization and HIV infection: development of novel contraceptive microbicides.

Doncel GF.

Hum Reprod Update. 2006 Mar-Apr;12(2):103-17. Epub 2005 Sep 19. Review.

15.

Theory-based interventions for contraception.

Lopez LM, Tolley EE, Grimes DA, Chen-Mok M.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD007249. doi: 10.1002/14651858.CD007249.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(3):CD007249.

PMID:
19160330
16.

Delivering on MPTs: addressing the needs, rising to the challenges and making the opportunities.

Malcolm RK, Fetherston SM.

Contraception. 2013 Sep;88(3):321-5. doi: 10.1016/j.contraception.2013.06.009. Epub 2013 Jun 18. No abstract available.

PMID:
23890794
17.
18.

Preclinical evaluation of sodium cellulose sulfate (Ushercell) as a contraceptive antimicrobial agent.

Anderson RA, Feathergill KA, Diao XH, Cooper MD, Kirkpatrick R, Herold BC, Doncel GF, Chany CJ, Waller DP, Rencher WF, Zaneveld LJ.

J Androl. 2002 May-Jun;23(3):426-38.

19.

Making the case for multipurpose prevention technologies: the socio-epidemiological rationale.

Boonstra H, Barot S, Lusti-Narasimhan M.

BJOG. 2014 Oct;121 Suppl 5:23-6. doi: 10.1111/1471-0528.12851.

20.

Contraception and sexually transmitted diseases: interactions and opportunities.

McGregor JA, Hammill HA.

Am J Obstet Gynecol. 1993 Jun;168(6 Pt 2):2033-41. Review.

PMID:
8512049
Items per page

Supplemental Content

Write to the Help Desk